Researchers have reported that CD40LG has a potent anti-tumor effect, which can be attributed to the CD40L–CD40LG interactions and can induce anti-tumor immunity by eliminating tumor-specific CD4+ and CD8+ tolerance (Sotomayor et al., 1999; Schmitz et al., 2001). Here, CD8A is linked to neoplasm.